Evan Lebois will be giving a talk at AD/PD 2025 on Thu, April 4th, 2025 at 10:10 am in Hall F1. Come hear him talk about: Novel small molecule EPHB3 inhibitors to treat neurodegenerative disease by targeting astrocyte-mediated disease mechanisms (ID 2437)
关于我们
Violet Therapeutics is a pre-clinical stage company leveraging a first-in-class platforms to identify, map and mine cell-to-cell communication at scale. Violet’s drug discovery programs are focused on CNS diseases enabled by the novel targets elucidated by their platforms. Violet was co-founded in 2021 by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital.
- 网站
-
www.violettx.com
Violet Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Cambridge，MA
- 类型
- 私人持股
地点
-
主要
获取路线
US，MA，Cambridge，02139